Standards play an important role in the global medicines supply chain, helping governments and manufacturers increase the availability of safe, quality medicines, as well as building patient and health provider trust. In fact, quality standards are a big reason why we in the U.S. can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should.
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for the 76th meeting of the World Health Assembly (WHA), the decision-making body of the World Health Organization (WHO).
Many patients and consumers have a mental picture of the last leg of the pharmaceutical supply chain as a neighborhood drug store where they pick up their prescriptions. The advent of the Internet age, however, renders that picture incomplete at best.
In today’s pharmaceutical manufacturing environment, companies face increasing pressure to respond to changing demands across the global medicines supply chain while still maintaining the quality of their drug products. The U.S.
The U.S. Pharmacopeia (USP) has long been recognized as an international leader in medicines quality and supply chain integrity.
It is not uncommon for people to sometimes take important things for granted, such as the quality of the medicines they rely on for their health. While not usually top-of-mind, standards and other quality-focused solutions developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S. Pharmacopeia (USP) support the availability of safe, quality medicines, regulatory efficiencies, and a strong global medicine supply chain.
Show 11 More